Blog

  • Market Open: Sizewell B Extension, Computacenter Profit Growth

    Market Open: Sizewell B Extension, Computacenter Profit Growth

    FTSE 100 edges lower as Centrica backs Sizewell B extension, Computacenter forecasts stronger profits and Brent crude eases.

    Market Overview

    The FTSE 100 opened marginally lower at 10,487.89, while the Euronext 100 gained 0.16 per cent and Germany’s DAX advanced 0.44 per cent. Overnight, the Nasdaq closed higher at 25,870.65, while the S&P 500 finished lower at 7,482.71. Investor sentiment remained cautious as markets assessed renewed geopolitical tensions following the collapse of the US-Iran ceasefire, while European equities attempted to stabilise after the previous session’s sharp losses.

    Against sterling, the US dollar strengthened slightly while the Swiss franc, euro, Japanese yen and Australian dollar all edged firmer. Bitcoin was up. In commodities, copper advanced, while gold, Brent crude and natural gas all eased, with oil continuing to reflect geopolitical risks in the Middle East despite softer prices at the open.


    Market Numbers

    FTSE 100: Down (-0.01%), 10,487.89

    Euronext 100: Up (+0.16%), 1,895.27

    DAX: Up (+0.44%), 25,006.76

    NASDAQ: Up, 25,870.65

    S&P 500: Down, 7,482.71


    In the Headlines

    Nuclear agreement – Centrica (LSE:CNA)

    Centrica has agreed a 20-year contract supporting the extension of the Sizewell B nuclear power station, helping secure long-term low-carbon electricity generation and reinforcing the UK’s energy security strategy.

    Trading update – Computacenter (LSE:CCC)

    Computacenter expects first-half profit to more than double compared with 2025, reflecting stronger trading performance and indicating improving momentum across its technology services business.


    Currencies (vs GBP)

    USD: Down (-0.00%), $1.3394

    CHF: Down (-0.08%), Fr.1.0824

    EUR: Down (-0.03%), €1.1727

    JPY: Down (-0.01%), ¥217.703

    AUD: Down (-0.01%), $1.931

    Bitcoin (BTC/GBP): Up, £46,967.94


    Commodities

    Copper: Up

    Gold: Down

    Brent Crude: Down

    Natural Gas: Down

  • European Stocks Advance as Technology Sector Recovers and Investors Track Middle East Developments: DAX, CAC, FTSE100

    European Stocks Advance as Technology Sector Recovers and Investors Track Middle East Developments: DAX, CAC, FTSE100

    European equity markets moved higher in volatile trading on Thursday, supported by a strong rebound in technology shares as investors assessed the latest developments in the Middle East after U.S. President Donald Trump said Iran wanted to “make a deal”.

    The pan-European STOXX 600 index gained 0.5% to 639.12 points by 08:16 GMT. Technology and basic resources led sector performance, advancing 1.8% and 2.8% respectively.

    Semiconductor-related stocks drove much of the rally, with Siltronic (TG:WAF) surging 10.5%, Soitec (EU:SOI) rising 4.5% and ASML (EU:ASML) adding 2.6%.

    The technology sector had paused after recording its strongest quarterly performance since 2001 in June, and Thursday’s recovery suggested investors were temporarily looking beyond concerns over stretched valuations. Even so, the sector remains the weakest performer on the STOXX 600 so far this month.

    Market sentiment also received support from reports that China could permit domestic artificial intelligence companies to access Nvidia’s (NASDAQ:NVDA) H200 chips on a limited basis, raising expectations of continued investment in AI infrastructure.

    Oil prices edged lower as investors continued to monitor geopolitical developments. Energy markets remained focused on the conflict between the United States and Iran after fresh U.S. strikes followed President Trump’s statement on Wednesday that negotiations with Tehran were over, contributing to the STOXX 600’s largest one-day decline since March.

    “Positive developments around the AI trade are supporting sentiment, but it’s not simply a case of AI outweighing concerns over U.S.-Iran tensions. Investors have also become a little more immune to developments in that story, viewing them as part of what has always been a choppy path towards a broader agreement,” said Fiona Cincotta, senior market analyst at City Index.

    Spanish equities outperformed the wider European market, climbing 1.1% after recovering from a three-week low reached on Wednesday. The rebound followed President Trump’s comments describing Spain as “very generous” after his decision to halt trade with the country over its NATO contribution.

    Company Movers

    Healthcare was the weakest-performing sector, falling 1.5%, largely due to a 9.1% decline in AstraZeneca (LSE:AZN). The pharmaceutical company came under pressure after its experimental drug Wainua, developed with U.S.-based Ionis, failed to meet the primary objective of reducing cardiovascular deaths and recurrent heart complications in a late-stage clinical trial.

    Elsewhere, IT services company Computacenter (LSE:CCC) surged 11.1% after forecasting full-year results comfortably ahead of market expectations, supported by continued strong demand for AI-related infrastructure.

    Wind turbine manufacturer Nordex (TG:NDX1) gained 5% after reporting that second-quarter project orders increased year-on-year to 3,054 MW, driven by significant contract wins in the United States.

  • TotalEnergies Sells European Distributed Solar Portfolio to Focus on Utility-Scale Renewables

    TotalEnergies Sells European Distributed Solar Portfolio to Focus on Utility-Scale Renewables

    TotalEnergies SE (EU:TTE) has completed the sale of its entire European distributed solar portfolio as the French energy group reshapes its renewable energy strategy to concentrate on large-scale solar and wind projects.

    The announcement follows a positive session for the company’s shares, which finished higher yesterday after oil prices recovered amid renewed geopolitical tensions between the United States and Iran.

    The transaction covers approximately 170 MW of distributed solar assets, primarily rooftop photovoltaic (PV) systems located in France, Belgium, the Netherlands, Spain, Portugal, the UK and Luxembourg. The portfolio has been acquired by independent renewable energy producer Amarenco together with AMPYR Distributed Energy, which will take ownership and operational control of the assets.

    The companies did not disclose the financial terms of the transaction.

    The disposal forms part of TotalEnergies’ 2026–2030 Strategy and Outlook, under which the company plans to reduce capital and operating expenditure by USD 7.5 billion (EUR 6.55 billion) in response to an uncertain macroeconomic environment. The strategy includes monetising renewable assets in non-core markets while accelerating investment in battery energy storage to benefit from electricity price volatility. TotalEnergies said its business model is better suited to developing utility-scale renewable projects, where economies of scale are greater, than smaller distributed generation assets of less than 3 MW. The company added that the divestment will not affect its wider renewable energy development plans.

    Over the past 12 months, TotalEnergies has commissioned 8 GW of gross renewable generating capacity, bringing its total installed renewable portfolio to 35 GW at the end of March. The group intends to maintain that annual deployment rate through 2030, with the objective of exceeding 75 GW of installed capacity and achieving net electricity production of 100 TWh.

  • FTSE 100 Slips as Middle East Tensions Rise and AstraZeneca Weighs on Index

    FTSE 100 Slips as Middle East Tensions Rise and AstraZeneca Weighs on Index

    The FTSE 100 traded lower on Thursday as investors reacted to escalating tensions in the Middle East, while shares in AstraZeneca (LSE:AZN) declined sharply after disappointing late-stage clinical trial results. The UK benchmark index fell 0.49% by 03:30 ET (07:30 GMT), lagging its European counterparts. Germany’s DAX advanced 0.61%, France’s CAC 40 gained 0.45%, and sterling strengthened 0.30% against the U.S. dollar to $1.3426.

    Investor sentiment remained fragile after U.S. Central Command confirmed overnight strikes on around 90 Iranian military targets, including air defence systems, missile and drone storage facilities, and naval infrastructure along Iran’s coastline. The operation marked a second consecutive night of military action aimed at reducing Tehran’s ability to threaten commercial shipping through the Strait of Hormuz.

    Iran responded by launching attacks targeting U.S.-allied Gulf states. Kuwait said its air defence systems intercepted incoming drones and missiles, while Bahrain activated air raid sirens and urged residents to seek shelter. Iran’s Revolutionary Guard claimed responsibility for attacks on both countries, with Qatar also reported to have been targeted. No immediate reports of significant damage were released.

    The latest escalation follows comments by U.S. President Donald Trump at the NATO summit in Ankara, where he declared that last month’s ceasefire with Iran was “over” after renewed attacks on commercial tankers in the Strait of Hormuz. Speaking aboard Air Force One, Trump later said Iran had reopened communication channels, stating, “They want to make a deal so badly,” before adding, “I just don’t know if they’re worthy of making a deal.”

    Vice President JD Vance also reiterated Washington’s position during remarks in Milwaukee, saying, “If they shoot at ships, we’re going to knock the hell out of them.”

    In commodity markets, Brent crude slipped 0.53% to $77.58 a barrel, while U.S. West Texas Intermediate crude eased 0.48% to $73.11. Gold continued to benefit from safe-haven demand, with futures rising 0.85% to $4,116.92 per ounce and spot gold advancing 0.74% to $4,107.82.

    UK Market Round-Up

    AstraZeneca (LSE:AZN) came under pressure after announcing that its experimental heart treatment Wainua failed to achieve the primary endpoint in a late-stage clinical trial, limiting its plans to expand the therapy beyond its current approved use.

    Computacenter (LSE:CCC) upgraded its outlook after reporting stronger-than-expected trading, forecasting that first-half adjusted pre-tax profit will be nearly double the level recorded a year earlier. The company also expects full-year 2026 earnings to come in comfortably ahead of current market forecasts.

    Informa (LSE:INF) announced that former Reuters chief executive Tom Glocer has been appointed chair-elect and will succeed John Rishton as chair in 2027 as part of a planned leadership transition.

    Capita (LSE:CPI) warned that issues related to its Civil Service Pension Scheme contract will reduce adjusted operating profit by between £25 million and £40 million this year, while also lowering free cash flow by £35 million to £50 million.

  • Hugo Boss Rejects Frasers Group Bid, Says €38 Offer Undervalues Business (FRAS)

    Hugo Boss Rejects Frasers Group Bid, Says €38 Offer Undervalues Business (FRAS)

    Hugo Boss (TG:BOSS) has urged shareholders to reject the voluntary takeover offer from Frasers Group (LSE:FRAS), with both its management and supervisory boards stating that the British retailer’s €38-per-share proposal does not adequately reflect the company’s long-term value or future growth prospects.

    Frasers Group, which owns Sports Direct and is Hugo Boss’s largest shareholder, announced the offer last month. However, the German fashion group said the bid significantly undervalues the business as it continues to execute its strategic plan through 2028.

    “The offer does not reflect the standalone prospects and future value creation potential of Hugo Boss,” the company said. “On this basis, the Managing Board and Supervisory Board recommend that shareholders do not accept the offer.”

    Hugo Boss shares were little changed in European trading by 08:18 GMT following the recommendation.

    The company also noted that the €38 offer represents the minimum price permitted under German takeover regulations. The figure is based on the highest price Frasers Group paid for Hugo Boss shares during the six months preceding the offer and, according to the board, should not be viewed as an assessment of the company’s intrinsic value.

    Shares in Hugo Boss surged when Frasers Group announced its proposal last month, valuing the fashion retailer at approximately $2.3 billion. At the time, Hugo Boss described the approach as uncoordinated and confirmed that its board would conduct a formal review. The offer values the company’s outstanding shares at around €2 billion.

    Following the announcement, analysts at JPMorgan said the proposal was likely to provide a near-term floor for the share price but saw limited scope for a competing offer to emerge.

    Hugo Boss shares remain well below the levels seen three years ago as the company continues to implement its turnaround strategy. Its “Claim 5 Touchdown” plan focuses on modernising stores, streamlining product ranges and expanding its womenswear business. Through the strategy, the company is targeting an EBIT margin of around 12% and average annual free cash flow of approximately €300 million by 2028, supported by stronger brand positioning, improved distribution and greater operational efficiency.

  • Saga Shares Climb After Berenberg Starts Coverage with Buy Rating (SAGA)

    Saga Shares Climb After Berenberg Starts Coverage with Buy Rating (SAGA)

    Saga (LSE:SAGA) shares gained 4.0% during Thursday’s trading session, rising to 612.6p after Berenberg initiated coverage of the specialist provider for the over-50s market with a Buy recommendation and a price target of 1,025p. The target suggests potential upside of around 62% from the previous closing price of 589p.

    The broker’s initiation attracted strong investor attention at the market open, with Berenberg outlining several factors supporting a more positive outlook for the company.

    A key element of the investment case is Saga’s 20-year affinity insurance partnership with Ageas, which began in mid-2025 after the company sold its underwriting business for £67.5 million. Berenberg believes the agreement transforms Saga’s insurance operations into a capital-light broking model, improving the group’s long-term financial profile.

    The analysts also highlighted continued strength in Saga’s Ocean Cruise division, together with a significant reduction in net debt, as evidence that the company is making solid progress in strengthening its balance sheet and executing its turnaround strategy.

    Saga’s share price performance contrasted with a more subdued broader market. The FTSE 100 traded cautiously on 9 July as investors remained focused on rising geopolitical tensions in the Middle East after comments from U.S. President Donald Trump that the Iran ceasefire was “over” weighed on sentiment and pushed oil prices higher. Against that backdrop, Berenberg’s positive assessment provided a company-specific catalyst that helped Saga outperform the wider market.

    The combination of a favourable analyst initiation, a price target substantially above the current share price and confidence in the company’s ongoing transformation was enough to trigger a strong re-rating in the shares despite the uncertain market environment.

    Following the latest gains, Saga shares remain within reach of their 52-week high of 680p, suggesting positive momentum could continue if additional analyst support emerges.

  • Goldman Sachs Turns Positive on Glencore, Citing Copper and Zinc Strength (GLEN)

    Goldman Sachs Turns Positive on Glencore, Citing Copper and Zinc Strength (GLEN)

    Glencore PLC (LSE:GLEN) received an upgrade from Goldman Sachs on Thursday, with the investment bank raising its recommendation to Buy from Neutral. The broker said the diversified miner is well placed to benefit from favourable market conditions in copper, zinc and metallurgical coal, even as it remains cautious on the outlook for iron ore.

    Shares in Glencore climbed 3.5% to 507.80 pence in London trading, comfortably outperforming the FTSE 100, which gained around 0.7% during the session.

    Although Goldman Sachs reduced its 12-month price target to £6.30 from £6.60, it said the recent weakness across the mining sector has created a more attractive valuation. The revised target continues to indicate significant upside from the current share price.

    According to the broker, Glencore offers one of the strongest combinations of exposure to its preferred commodities, together with potential earnings upside from its marketing division and an attractive valuation compared with other diversified mining companies.

    Goldman expects copper prices to remain well supported by tightening global mine supply and the possibility of U.S. import tariffs. It also believes zinc fundamentals remain favourable due to ongoing shortages of concentrate supply. In addition, the bank has become more optimistic about metallurgical coal following supply disruptions in China’s Shanxi province and expectations of seasonal restocking demand from India and China later this year.

    The broker also highlighted additional upside potential from Glencore’s marketing business, pointing to elevated volatility in energy markets and ongoing dislocations across the physical copper and aluminium markets. Goldman added that potential asset sales—including infrastructure holdings, Glencore’s remaining stake in Bunge and selected mining investments—could provide additional capital for enhanced shareholder returns over the next 12 to 18 months.

    Looking more broadly across the sector, Goldman Sachs reiterated its positive view on European mining companies with significant exposure to copper and aluminium. The bank maintained Buy ratings on Antofagasta, Norsk Hydro and Lundin Mining, while continuing to take a more cautious stance on iron ore, warning that weaker steel demand could push prices towards $90 to $95 per tonne.

  • GlobalData Reports Steady First-Half Growth While Expanding Pharma Intelligence Business and Shareholder Returns (DATA)

    GlobalData Reports Steady First-Half Growth While Expanding Pharma Intelligence Business and Shareholder Returns (DATA)

    GlobalData (LSE:DATA) delivered modest growth during the first half of 2026, with revenue increasing by around 3%, underlying revenue rising approximately 1% and adjusted EBITDA improving by between 4% and 5%. The company said trading continued to be affected by longer sales cycles and a challenging macroeconomic backdrop. However, renewal rates remained strong at around 89%, while contracted forward revenue increased by roughly 6%, reflecting the resilience of its subscription-based business model and proprietary data offering.

    As it reaches the conclusion of its current Growth Transformation Plan, GlobalData is reshaping its operating model by combining its AI-enabled platform with market-focused business units and updated go-to-market strategies aimed at accelerating future growth. During the period, the company completed the acquisition of Cambridge Healthcare, strengthening its competitive intelligence capabilities for global pharmaceutical customers. It also secured additional financing capacity and announced a £30 million tender offer at 85 pence per share, bringing planned shareholder returns for the year to £45 million, plus a further £8 million carried forward from previous plans. Management expects to outline its next phase of strategic development in September.

    The company also continues to enhance its artificial intelligence capabilities through the integration of its Ava AI Research Assistant into Microsoft 365 Copilot. GlobalData believes this will increase customer engagement by embedding its proprietary intelligence more deeply into clients’ daily workflows. The board also stated that it believes the combined value of the group’s individual businesses exceeds its current market valuation. Although adjusted EBITDA for the full year is expected to come in towards the lower end of market expectations, management remains focused on disciplined execution, targeted acquisitions, margin improvement and sustainable revenue growth.

    GlobalData’s outlook continues to benefit from stable revenue growth and dependable cash generation. However, higher debt levels and reduced shareholders’ equity have increased balance sheet risk. Technical indicators point to improving share price momentum, although overbought conditions and a share price still below the 200-day moving average suggest some caution. Valuation appears broadly reasonable, supported by a mid-20s price-to-earnings ratio and a modest dividend yield.

    More about GlobalData

    GlobalData Plc is a provider of subscription-based data, analytics and technology solutions serving enterprise customers across healthcare and a wide range of commercial industries. Its AI-enabled Connected Intelligence platform combines proprietary datasets, industry expertise and artificial intelligence to deliver market intelligence and decision-support tools. The platform includes the Ava AI Research Assistant, which is integrated into Microsoft 365 Copilot to help customers access actionable insights within their everyday workflows.

    The company generates the majority of its revenue through recurring subscriptions and maintains high customer renewal rates. With particular strength in pharmaceutical intelligence alongside broader commercial markets, GlobalData continues to pursue long-term growth through organic expansion, targeted acquisitions and disciplined capital allocation.

  • Bytes Technology Group Delivers Strong Start to the Year with Continued Double-Digit Growth (BYIT)

    Bytes Technology Group Delivers Strong Start to the Year with Continued Double-Digit Growth (BYIT)

    Bytes Technology Group (LSE:BYIT) has reported a strong performance during the first four months of its financial year, achieving double-digit year-on-year growth in both gross invoiced income and gross profit across its private and public sector customer base. Operating profit remained broadly unchanged over the period, with management stating that trading continues to track previous guidance.

    The company said its performance reflects continued progress in executing its strategy to increase market share across the rapidly expanding artificial intelligence, cloud computing and cybersecurity sectors. Growth has been supported by longstanding relationships with major technology vendors, strong customer demand and continued investment in its workforce, positioning the business to capitalise on increasing enterprise technology spending.

    Bytes Technology’s outlook continues to be supported by strong underlying financial fundamentals, including consistent growth, healthy profitability and a conservatively positioned balance sheet with very low leverage. Valuation also remains attractive, with a relatively low price-to-earnings ratio complemented by a strong dividend yield. While technical indicators remain positive, overbought momentum signals suggest the shares could be vulnerable to a short-term pullback.

    More about Bytes Technology Group

    Bytes Technology Group plc is one of the leading providers of software, cloud and IT solutions across the UK and Ireland. The company specialises in helping organisations procure, deploy and manage technology, with particular expertise in artificial intelligence, cloud computing and cybersecurity. Bytes serves a broad base of corporate and public sector customers and is listed on both the London Stock Exchange’s Main Market and the Johannesburg Stock Exchange.

  • Centrica Agrees 20-Year Contract to Extend Sizewell B Nuclear Power Station (CAN)

    Centrica Agrees 20-Year Contract to Extend Sizewell B Nuclear Power Station (CAN)

    Centrica (LSE:CAN) has reached Heads of Terms with the UK Government for a 20-year regulated Contract for Difference (CfD) that will support the continued operation of the Sizewell B nuclear power station beyond its current planned closure date. The agreement extends the plant’s lifespan from 2035 to 2055 and provides a CPI-linked strike price of £70.50 per megawatt hour, giving the project long-term revenue certainty while eliminating exposure to wholesale electricity price fluctuations.

    The agreement supports an investment programme of approximately £800 million to extend the life of the 1.2GW nuclear facility. Centrica said the funding will be provided through existing nuclear cash flows, avoiding the need to raise new equity. Sizewell B currently generates around 3% of the UK’s electricity and supplies enough zero-carbon power for approximately 2.5 million homes. The new regulated framework provides greater visibility over future earnings while strengthening Centrica’s portfolio of long-term energy infrastructure assets.

    The extension also complements Centrica’s broader nuclear strategy, which includes its investment in the planned Sizewell C power station and its involvement in advanced modular reactor projects. The company believes the agreement will support UK energy security, protect highly skilled jobs and deliver long-term value for both customers and shareholders through stable, inflation-linked returns.

    Centrica’s financial outlook remains supported by strong revenue growth and consistently positive free cash flow. However, these strengths are partly offset by volatility in bottom-line earnings, including a net loss reported in 2025, and a balance sheet that remains moderately leveraged. Technical indicators are broadly supportive, with the shares trading above key longer-term moving averages, while valuation appears reasonable based on a moderate price-to-earnings ratio and dividend yield.

    More about Centrica

    Centrica plc is a London-listed energy company with a 20% ownership interest in the UK’s operational nuclear power fleet, including the 1.2GW Sizewell B station in Suffolk. Alongside its existing nuclear assets, the company is investing in future low-carbon generation through its stake in the proposed 3.2GW Sizewell C project and its involvement in advanced modular reactor technologies.

    Centrica’s nuclear investments operate under regulated frameworks, including Contracts for Difference and the Regulated Asset Base model, providing predictable, inflation-linked revenues. The company’s strategy is focused on supporting the UK’s transition to secure, low-carbon baseload electricity while generating stable long-term returns for shareholders.